Search This Blog

Monday, January 9, 2023

Revance Update on DAXXIFY® Commercial Launch and Prelims

 

  • DAXXIFY® PrevU program off to strong start with ~400 select practice partners and thousands of patients treated, generating positive feedback and strong, early uptake

  • Preliminary unaudited Q4 DAXXIFY® revenue from PrevU of between $10.5 million and $11.5 million

  • Preliminary unaudited Q4 RHA® Collection revenue of between $34.0 million and $35.0 million, a YoY increase of approximately 45%

  • Aesthetic accounts across products and services totaled over 5,000 at the end of the fourth quarter 2022

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.